Next Article in Journal
Influenza Vaccination in Adults in the United States with COPD before and after the COVID-19 Pandemic (2017–2022): A Multi-Year Cross-Sectional Study
Next Article in Special Issue
Dose Considerations for Vaccinia Oncolytic Virus Based on Retrospective Reanalysis of Early and Late Clinical Trials
Previous Article in Journal
Maternal Immunization with Adjuvanted Recombinant Receptor-Binding Domain Protein Provides Immune Protection against SARS-CoV-2 in Infant Monkeys
Previous Article in Special Issue
The Role of Natural Killer Cells in Oncolytic Virotherapy: Friends or Foes?
 
 
Due to scheduled maintenance work on our database systems, there may be short service disruptions on this website between 10:00 and 11:00 CEST on June 14th.
Review

Article Versions Notes

Vaccines 2024, 12(8), 930; https://doi.org/10.3390/vaccines12080930
Action Date Notes Link
article xml file uploaded 21 August 2024 06:41 CEST Original file -
article xml uploaded. 21 August 2024 06:41 CEST Update -
article pdf uploaded. 21 August 2024 06:41 CEST Version of Record https://www.mdpi.com/2076-393X/12/8/930/pdf-vor
article html file updated 21 August 2024 06:43 CEST Original file -
article xml file uploaded 22 August 2024 09:09 CEST Update -
article xml uploaded. 22 August 2024 09:09 CEST Update https://www.mdpi.com/2076-393X/12/8/930/xml
article pdf uploaded. 22 August 2024 09:09 CEST Updated version of record https://www.mdpi.com/2076-393X/12/8/930/pdf
article html file updated 22 August 2024 09:10 CEST Update https://www.mdpi.com/2076-393X/12/8/930/html
Back to TopTop